B. Riley
http://www.brileyco.comB. Riley provides investment banking services to wide range of companies, as well as research and trading ideas to individual and institutional clients.
View Older Stories View More Recent Stories
-
AppHarvest announces Q1 2022 results with highest quarterly net sales to date, remains on track to open three new high-tech indoor farms by end of 2022
-
AppHarvest announces Q1 2022 results with highest quarterly net sales to date, remains on track to open three new high-tech indoor farms by end of 2022
-
Horizon Technology Finance Announces First Quarter 2022 Financial Results
-
Form 4 B. Riley Financial, Inc. For: May 03 Filed by: RILEY BRYANT R
-
Form 4 B. Riley Financial, Inc. For: May 02 Filed by: RILEY BRYANT R
-
Form 4 B. Riley Financial, Inc. For: May 02 Filed by: Moore Andrew
-
Form 4 B. Riley Financial, Inc. For: May 02 Filed by: Young Kenneth M
-
Form 4 B. Riley Financial, Inc. For: May 02 Filed by: PAULSON RANDALL E
-
Form 4 B. Riley Financial, Inc. For: May 02 Filed by: Sheldon Michael Joseph
-
Form 4 B. Riley Financial, Inc. For: May 02 Filed by: ANTIN ROBERT L
-
Transphorm to Participate in May 2022 Investor Conferences
-
Quantum to Participate at Upcoming Investor Conferences
-
Moses & Singer Launches Healthcare/Life Sciences Privacy and Cybersecurity Consulting Firm MS Strategic Solutions
-
Aspen Aerogels to Participate in May Investor Conferences
-
Form S-4/A B. Riley Principal 150
-
Form 10-Q B. Riley Financial, Inc. For: Mar 31
-
The AZEK Company Announces Upcoming Investor Conference Schedule
-
Sono Group (SEV) Prices 10M Share Follow-on Offering at $4/sh
-
Sono Motors Announces Pricing of Follow-on Offering
-
Sono Motors Announces Pricing of Follow-on Offering
-
Form SC 13D/A QUANTUM CORP /DE/ Filed by: B. Riley Financial, Inc.
-
B. Riley Financial (RILY) Reports Q1 Loss of $0.43
-
Form 8-K B. Riley Financial, Inc. For: Apr 20
-
Meta Financial Group, Inc.® Announces Results for 2022 Fiscal Second Quarter
-
B. Riley Financial Reports First Quarter 2022 Results
-
LifeMD to Participate in the Upcoming May Conferences
-
Form S-4/A B. Riley Principal 150
-
Alpha and Omega Semiconductor to Participate in Upcoming Investor Conferences
-
Ribbon Communications Inc. Reports First Quarter 2022 Financial Results
-
AC Immune to Present at the B. Riley Annual Neuro & Ophthalmology Virtual Investor Conference
-
Gain Therapeutics to Participate in the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference
-
Gain Therapeutics to Participate in the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference
-
Sono Group (SEV) Announces 10M Share Follow-on Offering
-
Sono Motors Announces Follow-on Offering
-
Sono Motors Announces Follow-on Offering
-
Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference
-
Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference
-
Financial Advisor Michael Gavett Joins Linsco by LPL Financial
-
Financial Advisor Michael Gavett Joins Linsco by LPL Financial
-
Quantum Corporation Successfully Raises $67.5 Million in Oversubscribed Rights Offering; Strengthens Balance Sheet and Amends Debt Covenants
-
Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th
-
B. Riley Securities Expands Fixed Income Division with Two Key Managing Director Hires, Ji Pak and Mary Jo Collins
-
Lineage to Present at B. Riley Securities 2022 Neuro & Ophthalmology Virtual Investor Conference on April 27, 2022
-
Iveric Bio to Participate in the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference
-
TG Therapeutics to Participate in the B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference
-
Anavex Life Sciences Invited to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference
-
INmune Bio, Inc. to Participate at the B. Riley Neuro & Ophthalmology Conference
-
INmune Bio, Inc. to Participate at the B. Riley Neuro & Ophthalmology Conference
-
Cassava Sciences Invited to Participate in B. Riley Securities’ Neuroscience Conference
-
Dr. Henry Ji, Sorrento Therapeutics’ Chairman and CEO and Scilex Holding Company’s Executive Chairman, to Present at the B. Riley Securities’ 2022 Virtual Neuro & Opthalmology Healthcare Con

